AVE 33.3% 0.2¢ avecho biotechnology limited

oxymorphone trials begin, page-40

  1. 5,756 Posts.
    lightbulb Created with Sketch. 308
    Thats an interesting point Jev. Orals do get forgotten with so many different areas and so much focus on transdermal.

    Could injectables be formulated to be oral with TPM as they should avoid the digestive system?
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.